|2021 Plenary speakers|
Breaking the glyco-code of HIV immunopathogenesis
Impact of stress on integrative health and disease
Children and adolescents: focus on HIV-associated co-morbidities – what will the future hold?
Roundtable: post-acute sequelae of SARS-CoV-2 infection
Professor Mohamed Abdel-Mohsen is an Assistant Professor at The Wistar Institute, Wistar Assistant Professor at the University of Pennsylvania, and co-director of the Penn Centers for AIDS Research (CFAR) Virus and Reservoirs Core. He has published 60 peer-reviewed papers on the molecular pathogenesis of HIV infection. These papers reflect broad interests in the field of HIV, ranging from the iPrEx study to his work in the Delaney AIDS Research Enterprise to Cure HIV and Sustainable East Africa Research of Community Health Global studies, to his work describing novel immune mechanisms controlling HIV pathogenesis and persistence. In 2017, he joined Wistar Institute after completing his Ph.D. and postdoctoral training at the University of California, San Francisco. His laboratory investigates the role of the host glycosylation machinery in modulating HIV persistence and immunopathogenesis. They aim to discover novel glycan-based interactions that can be targeted to cure HIV and/or improve tolerance of lifelong infection.
Judith S. Currier, MD, MSc is Professor of Medicine, Chief of the Division of Infectious Diseases and Director of the Center for AIDS Research and Education Center and the Sue and Michael Steinberg Endowed Chair in Global AIDS Research in the Department of Medicine at UCLA. She is Chair of the NIH sponsored AIDS Clinical Trials Group and the Principal Investigator of the Leadership Operations Center (LOC) for the ACTG based at UCLA. She also serves as the Principal Investigator of the UCLA AIDS Prevention and Treatment Clinical Trials Unit based at UCLA. In March of 2020 she was appointed as a Member of the Therapeutics Working Group for the NIH Accelerating COVID -19 Therapeutics and Vaccines(ACTIV) Initiative. Her areas of research focus include understanding the pathogenesis and management of long term complications of HIV disease, specifically cardiovascular and metabolic complications associated with HIV treatment and on evaluating therapeutics for early COVID disease.
Dr. Deeks published over 600 peer-review articles, editorials and invited reviews on HIV and related topics. He has been the recipient of several NIH grants, and is one of the principal investigators of DARE (the Delaney AIDS Research Enterprise), an NIH-funded international collaboratory aimed at developing a cure for HIV infection. He is also the principal investigator of amfAR Institute for HIV Cure Research and the co-chair of the “Towards an HIV Cure” International Working Group. Dr. Deeks was elected to the American Society for Clinical Investigation (ASCI) and Association of American Physicians (AAP). He is the editor-in-chief of Current Opinion in HIV and AIDS and serves on the scientific advisory board for Science Translational Medicine and the advisory board for EBioMedicine.
In April, 2020, he leveraged his HIV research program to construct the “Long-term Impact of Infection with Novel Coronavirus (LIINC)” cohort, which is now supporting dozens of studies addressing the impact of SARS-CoV-2 on health.
Dr Deeks is a former member of the Office of AIDS Research Advisory Council (ORAC) and of the Department on Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents.
In addition to his clinical and translational investigation, Dr. Deeks maintains a primary care clinic for HIV infected patients.
Dr. Gretchen Neigh is currently an Associate Professor in the Department of Anatomy & Neurobiology at Virginia Commonwealth University School of Medicine. Dr. Neigh’s research focuses on understanding the biological mechanisms that dictate risk and resilience to stress exposure with the goal of determining how to prevent and treat mental and physical disease. In addition to research, she is actively engaged in supporting the development of the next generation of scientists from diverse backgrounds and is the Associate Director of the VCU MD/PhD Training Program and the Co-Director of the VCU Clinical and Translational PhD Training Program. Dr. Neigh has received funding from the National Institutes of Health and foundations. More information about her work can be found at: http://gretchenneigh.com
Professor Zühlke is a paediatric cardiologist in the Dept. of Paediatric Cardiology at Red Cross Children’s Hospital and directs the Children’s Heart Disease Research Unit focused on family-centred research into Children’s Heart Diseases of relevance in Africa. Her research projects span congenital and Rheumatic Heart disease, HIV in adolescents, Grown-up Congenital heart disease and cardiac disease in women of childbearing age. She was the recipient of the 2018 MRC/Dfid African research leader Award. She is the only female full Professor of Paediatric Cardiology in her country and is passionate about mentoring women and minority groups in Cardiology practice and leadership. She has delivered several talks in this regard and is part of the Lancet commission for Cardiovascular disease in Women. A speaker at all the premier international cardiology congresses, she recently delivered a lecture to the Academy of Medical Sciences in London on “Developing capacity for clinical research in low and middle-income countries”, another personal passion and was a designed rising star at the Gates Grand Challenges meeting held in Ethiopia in October 2019. She leads the PROTEA study” Partnerships for Congenital Heart Disease in Africa” focusing on describing the epidemiology and genetic origins of Congenital Heart Disease in several countries in Africa.